Pfizer and Samsung Medical Center (SMC) have formed a research partnership to jointly analyze tumors from Korean patients to generate gene expression profiles in an effort to direct therapies and enhance clinical outcomes in the patients with liver cancer. Pfizer has been investing in R&D of drug candidates and potential treatments for patients with liver cancer to address the growing need for drugs to treat liver cancer in the Asian market. SMC works to develop new anticancer drugs t...